NutriBand (NTRB) Total Debt Growth (5y) (2021 - 2026)
NutriBand (NTRB) Total Debt Growth (5y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
NutriBand |
39.29 Mn |
34.71 Mn |
196,801.00 |
| Date | Value |
|---|
| Apr 30, 2026 |
-23.20% |
| Jan 31, 2026 |
-24.89% |
| Oct 31, 2025 |
-24.40% |
| Jul 31, 2025 |
6.28% |
| Jan 31, 2025 |
-2.92% |
| Oct 31, 2024 |
-33.19% |
| Jan 31, 2024 |
14.82% |
| Oct 31, 2023 |
16.30% |
| Jul 31, 2023 |
17.68% |
| Apr 30, 2023 |
18.46% |
| Jan 31, 2023 |
28.02% |
| Oct 31, 2022 |
44.58% |
| Jul 31, 2022 |
131.82% |
| Apr 30, 2022 |
135.59% |
| Jan 31, 2022 |
62.63% |
| Oct 31, 2021 |
146.34% |
| Jul 31, 2021 |
147.02% |
| Jan 31, 2021 |
148.42% |
